Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial.

Chaibi, Sérine;Roy, Pierre-Marie;Guénégou, Armelle Arnoux;Tran, Yohann;HOME-PE study group;et.al.
(2024) Thrombosis research — Vol. 235, p. 79-87 (2024)

Files

2024_Chaibi_Thromb_Res.pdf
  • Restricted Access
  • Adobe PDF
  • 1.88 MB

Details

Authors
  • Chaibi, Sérine
    Author
  • Roy, Pierre-Marie
    Author
  • Guénégou, Armelle Arnoux
    Author
  • Tran, Yohann
    Author
  • Penaloza-Baeza, AndreaUCLouvain
    Author
  • HOME-PE study group
    Collaborator
Show more
Abstract
INTRODUCTION: Cancer-related pulmonary embolism (PE) is associated with poor prognosis. Some decision rules identifying patients eligible for home treatment categorize cancer patients at high risk of complications, precluding home treatment. We sought to assess the effectiveness and the safety of outpatient management of patients with low-risk cancer-associated PE. METHODS: In the HOME-PE trial, hemodynamically stable patients with symptomatic PE were randomized to either triaging with Hestia criteria or sPESI score. We analyzed 3 groups of low-risk PE patients: 47 with active cancer treated at home (group 1), 691 without active cancer treated at home (group 2), and 33 with active cancer as the only sPESI criterion qualifying them for hospitalization (group 3). The main outcome was the composite of recurrent venous thromboembolism, major bleeding, and all-cause death within 30 days after randomization. RESULTS: Patients treated at home had composite outcome rates of 4.3 % (2/47) for those with cancer vs. 1.0 % (7/691) for those without (odds ratio (OR) 4.98, 95%CI 1.15-21.49). Patients with cancer had rates of complications of 4.3 % when treated at home vs. 3.0 % (1/33) when hospitalized (OR 1.19, 95%CI 0.15-9.47). In multivariable analysis, active cancer was associated with an increased risk of complications for patients treated at home (OR 7.95; 95%CI 1.48-42.82). For patients with active cancer, home treatment was not associated with the primary outcome (OR 1.19, 95%CI 0.15-9.74). CONCLUSIONS: Among patients treated at home, active cancer was a risk factor for complications, but among patients with active cancer, home treatment was not associated with adverse outcomes.
Affiliations

Citations

Chaibi, S., Roy, P.-M., Guénégou, A. A., Tran, Y., Hugli, O., Penaloza-Baeza, A., Couturaud, F., Tromeur, C., Szwebel, T.-A., Pernod, G., Elias, A., Ghuysen, A., Benhamou, Y., Falvo, N., Juchet, H., Nijkeuter, M., Mairuhu, R., Faber, L. M., Mahé, I., et al. (2024). Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial. Thrombosis research, 235, 79-87. https://doi.org/10.1016/j.thromres.2024.01.014 (Original work published 2024)